Patents by Inventor Elankumaran Subbiah

Elankumaran Subbiah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES AND DIAGNOSTICS FOR NOVEL PORCINE ORTHOREOVIRUSES
    Publication number: 20180326034
    Abstract: Provided herein are diagnostics and vaccines to identify control and prevent novel porcine orthoreovirus type 3 (POV3) isolated from diarrheic feces of piglets from outbreaks in three states and ring-dried swine blood meal from multiple sources.
    Type: Application
    Filed: November 17, 2015
    Publication date: November 15, 2018
    Inventors: Xiang-Jin MENG, Dianjun CAO, Athmaram NARAYANAPPA, Elankumaran SUBBIAH
  • Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
    Patent number: 9803216
    Abstract: Recombinant strains of avian paramyxovirus (APMV), such as Newcastle disease virus (NDV), are provided. Also provided are compositions comprising them, and methods of using them to lyse tumor cells and to treat cancer. In certain aspects, genetically-engineered viral strains that incorporate therapeutic transgenes are also provided. The recombinant viruses may be used in accordance with methods of providing enhanced oncolytic efficacy and delivering an oncolytic virus to tumors present in a patient. Also provided are methods for identifying a recombinant virus as an oncolytically-effective agent.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: October 31, 2017
    Assignee: University of Maryland
    Inventors: Elankumaran Subbiah, Siba K. Samal
  • GENETICALLY-ENGINEERED NEWCASTLE DISEASE VIRUS AS AN ONCOLYTIC AGENT, AND METHODS OF USING SAME
    Publication number: 20140186303
    Abstract: Recombinant strains of avian paramyxovirus (APMV), such as Newcastle disease virus (NDV), are provided. Also provided are compositions comprising them, and methods of using them to lyse tumor cells and to treat cancer. In certain aspects, genetically-engineered viral strains that incorporate therapeutic transgenes are also provided. The recombinant viruses may be used in accordance with methods of providing enhanced oncolytic efficacy and delivering an oncolytic virus to tumors present in a patient. Also provided are methods for identifying a recombinant virus as an oncolytically-effective agent.
    Type: Application
    Filed: September 7, 2012
    Publication date: July 3, 2014
    Applicant: UNIVERSITY OF MARYLAND, COLLEGE PART,THE
    Inventors: Elankumaran Subbiah, Siba K. Samal
  • Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
    Publication number: 20090175826
    Abstract: Recombinant strains of avian paramyxovirus (APMV), such as Newcastle disease virus (NDV), are provided. Also provided are compositions comprising them, and methods of using them to lyse tumor cells and to treat cancer. In certain aspects, genetically-engineered viral strains that incorporate therapeutic transgenes are also provided. The recombinant viruses may be used in accordance with methods of providing enhanced oncolytic efficacy and delivering an oncolytic virus to tumors present in a patient. Also provided are methods for identifying a recombinant virus as an oncolytically-effective agent.
    Type: Application
    Filed: June 5, 2007
    Publication date: July 9, 2009
    Inventors: Elankumaran Subbiah, Siba K. Samal